NCT06458400View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 6, 2024

Conditions

Analgesia

Interventions

DRUG

Tegileridine

single dose+PCA dose

DRUG

Oliceridine

single dose+PCA dose

DRUG

Morphine

single dose+PCA dose

Trial Locations (1)

200000

241 Huaihai West Road, Xuhui District, Shanghai, Shanghai

All Listed Sponsors

lead

Yuwei Qiu

OTHER

NCT06458400 - To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain | Biotech Hunter | Biotech Hunter